Table 3.
Final fitted multivariate regression model.
| Variable | Coefficient | p value |
|---|---|---|
| Age (decades) | −4.20 | 0.036 |
| Sex (female) | +11.87 | 0.013 |
| Anti-VEGF | ||
| Bevacizumab | Reference | |
| Ranibizumab | −9.03 | 0.136 |
| Aflibercept | −11.88 | 0.097 |
| Improvement in binocular BCVA | +24.94 | 0.141 |
Adjusted R2 = 0.10. BCVA, best-corrected visual acuity.